The challenges in obesity research are significant, but the opportunities for innovation are equally profound.
Matt Wilson
Advertisement
Founder and CEO, uMed
Articles by Matt Wilson
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Foundayo Under National Priority Voucher Program
2
Biogen Enters $5.6 Billion Agreement to Acquire Apellis Pharmaceuticals
3
What Potential Fallout Will MFN Policies Have?
4
Pharmaceutical Executive Daily: Trump Administration Delays Appeal of Federal Ruling Blocking Vaccine Policy Overhaul
5